![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: WDR27 |
Gene summary for WDR27 |
![]() |
Gene information | Species | Human | Gene symbol | WDR27 | Gene ID | 253769 |
Gene name | WD repeat domain 27 | |
Gene Alias | WDR27 | |
Cytomap | 6q27 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | A2RRH5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
253769 | WDR27 | HTA11_3410_2000001011 | Human | Colorectum | AD | 8.16e-14 | -4.36e-01 | 0.0155 |
253769 | WDR27 | HTA11_2487_2000001011 | Human | Colorectum | SER | 1.79e-06 | -4.81e-01 | -0.1808 |
253769 | WDR27 | HTA11_78_2000001011 | Human | Colorectum | AD | 1.35e-08 | -4.29e-01 | -0.1088 |
253769 | WDR27 | HTA11_696_2000001011 | Human | Colorectum | AD | 2.43e-06 | -3.98e-01 | -0.1464 |
253769 | WDR27 | HTA11_866_2000001011 | Human | Colorectum | AD | 8.78e-04 | -3.63e-01 | -0.1001 |
253769 | WDR27 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.17e-07 | -4.06e-01 | 0.096 |
253769 | WDR27 | HTA11_10711_2000001011 | Human | Colorectum | AD | 6.13e-03 | -3.41e-01 | 0.0338 |
253769 | WDR27 | HTA11_7696_3000711011 | Human | Colorectum | AD | 1.13e-04 | -3.25e-01 | 0.0674 |
253769 | WDR27 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 2.06e-02 | -3.35e-01 | 0.281 |
253769 | WDR27 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 2.43e-02 | -2.69e-01 | 0.3859 |
253769 | WDR27 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 5.70e-03 | -4.35e-01 | 0.2585 |
253769 | WDR27 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 7.74e-09 | -3.98e-01 | 0.3005 |
253769 | WDR27 | A001-C-207 | Human | Colorectum | FAP | 6.02e-04 | -1.61e-01 | 0.1278 |
253769 | WDR27 | A015-C-203 | Human | Colorectum | FAP | 1.47e-12 | -3.25e-01 | -0.1294 |
253769 | WDR27 | A015-C-204 | Human | Colorectum | FAP | 1.33e-04 | -1.61e-01 | -0.0228 |
253769 | WDR27 | A014-C-040 | Human | Colorectum | FAP | 2.28e-03 | -1.90e-01 | -0.1184 |
253769 | WDR27 | A002-C-201 | Human | Colorectum | FAP | 1.94e-12 | -2.40e-01 | 0.0324 |
253769 | WDR27 | A001-C-119 | Human | Colorectum | FAP | 4.95e-04 | -1.83e-01 | -0.1557 |
253769 | WDR27 | A001-C-108 | Human | Colorectum | FAP | 3.16e-04 | -1.30e-01 | -0.0272 |
253769 | WDR27 | A002-C-205 | Human | Colorectum | FAP | 5.71e-20 | -2.79e-01 | -0.1236 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
WDR27 | SNV | Missense_Mutation | novel | c.143N>T | p.Asp48Val | p.D48V | A2RRH5 | protein_coding | deleterious(0) | possibly_damaging(0.827) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD |
WDR27 | SNV | Missense_Mutation | rs35927529 | c.2089N>A | p.Asp697Asn | p.D697N | A2RRH5 | protein_coding | deleterious(0) | probably_damaging(0.959) | TCGA-AX-A2HD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
WDR27 | SNV | Missense_Mutation | c.2384N>A | p.Pro795His | p.P795H | A2RRH5 | protein_coding | deleterious(0) | probably_damaging(0.99) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD | |
WDR27 | SNV | Missense_Mutation | novel | c.2405G>A | p.Cys802Tyr | p.C802Y | A2RRH5 | protein_coding | deleterious(0) | possibly_damaging(0.885) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
WDR27 | SNV | Missense_Mutation | rs369074175 | c.1858N>A | p.Ala620Thr | p.A620T | A2RRH5 | protein_coding | tolerated(0.14) | benign(0.015) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
WDR27 | SNV | Missense_Mutation | c.1381N>A | p.Ala461Thr | p.A461T | A2RRH5 | protein_coding | tolerated(0.15) | benign(0.053) | TCGA-D1-A174-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
WDR27 | SNV | Missense_Mutation | rs147471495 | c.2516C>T | p.Ala839Val | p.A839V | A2RRH5 | protein_coding | tolerated(0.11) | benign(0.007) | TCGA-D1-A17U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
WDR27 | SNV | Missense_Mutation | novel | c.2080N>A | p.Ala694Thr | p.A694T | A2RRH5 | protein_coding | deleterious(0.02) | possibly_damaging(0.744) | TCGA-D1-A1NY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | SD |
WDR27 | SNV | Missense_Mutation | c.476N>G | p.Tyr159Cys | p.Y159C | A2RRH5 | protein_coding | tolerated_low_confidence(0.17) | benign(0) | TCGA-DI-A0WH-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
WDR27 | SNV | Missense_Mutation | novel | c.2294N>C | p.Met765Thr | p.M765T | A2RRH5 | protein_coding | deleterious(0) | benign(0.151) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |